Point-of-care diagnostics maker Quidel announced this week that John Radak has been named CFO of the firm, succeeding Paul Landers. Radak joins Quidel from Invitrogen, where he served as vice president and chief accounting officer since 2003.
Swiss compounds research company Tecan last month said its board of directors has appointed and to its group executive committee.
Robin will be responsible for the company’s liquid-handling and robotics business, which is currently being managed by CEO Thomas Bachmann. Robin previously was CEO of medical technology company .
Severinghaus worked previously with Beckman Coulter and the American Monitor Corporation, and the and has 15 years experience working at Tecan.
In his new position he will manage the company’s direct sales organization.